← Back
$RCKT All transactions

ROCKET PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

407,166

Price

$0

Filed

Aug 6

Insider

Name

Stevens Christopher James

Title

Chief Operating Officer

CIK

0002079768

Roles

Officer

Transaction Details

Transaction Date

2025-08-04

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

407,166

Footnotes

Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years. | This option represents a right to purchase a total of 554,071 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.

Filing Info

Accession No.

0001140361-25-029144

Form Type

4

Issuer CIK

0001281895

Stevens Christopher James's History

Date Ticker Type Value
2025-08-04 RCKT A $0
2025-08-04 RCKT A $0

Other Insiders at RCKT (90d)

No other insider activity at this issuer in the last 90 days.